Patent · US Active

Tolerable and minimally invasive skin electroporation device

US11565107B2 · kind B2 · utility

0Cited by
7References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 1, 2011
Grant dateJan 31, 2023
Priority date
Expiry dateFeb 3, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A novel electroporation device for the delivery of vaccines that is both effective in generating a protective immune response and tolerable delivery to a subject (or near painless); and also methods of using same device to vaccinate a subject against a variety of infectious diseases and types of cancer in a near painless.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.